Rajiv Jalan

Fantastic paper attempting to bring two Groups of Cirrhosis Leadership together — Baveno / EFCLIF.. portal hypertension meets systemic inflammation. Must say this is an amazing paper. Looking forward to your thoughts…

01.10.2025 16:52 — 👍 3    🔁 0    💬 0    📌 0

Pathomechanistic #Phenotypes of #Cirrhosis

Dalila Costa🇵🇹 Jonel Trebicka🇩🇪 Cristina Ripoll🇪🇸 Richard Moreau🇫🇷 @rajivjalan.bsky.social🇬🇧 Reiberger🇦🇹

📈 Portal Hypertension #PH & 🔥 Inflammation #SI coexist in pts w/ cirrhosis

💡review on PH-SI interplay in distinct cirrhosis stages
@easlnews.bsky.social

30.09.2025 07:05 — 👍 6    🔁 2    💬 0    📌 1

Our @GeorgKRAMER myself & @CristinaRIPOLL perspective on staging of #Decompensated #Cirrhosis
- this was a Letter ✉️ to @jhepatology.bsky.social in response to an article by Dr. Verma @rajivjalan.bsky.social et al
#NonAcuteDecompensation (NAD) 🔗 t.ly/mc4VG
- who responded w/ an interesting proposal

28.09.2025 19:14 — 👍 3    🔁 2    💬 0    📌 0

Feel free to follow the new A-TANGO Consortium + #hepatology Starter Pack go.bsky.app/Tc8YSWq

#LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals

@rajivjalan.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@jhepatology.bsky.social
@ebtapper.bsky.social

25.04.2025 21:37 — 👍 8    🔁 7    💬 0    📌 0

Ammonia build-up kills liver cells but can be prevented using existing drug High levels of ammonia kill liver cells by damaging the mitochondria that power the cells. But this can be prevented using an existing drug due to start clinical trials, finds a new study in mice led ...

High ammonia levels kill liver cells by damaging their mitochondria, but this can be prevented using an existing drug due to start clinical trials, finds a new study in mice led by Prof Rajiv Jalan @rajivjalan.bsky.social from UCL Division of Medicine
www.ucl.ac.uk/news/2025/ma...

10.03.2025 16:11 — 👍 6    🔁 2    💬 0    📌 0

🚨 New Insights in Cirrhosis! 🚨

www.journal-of-hepatology.eu/article/S016...

Our study reveals Non-Acute Decompensation (NAD) is a distinct clinical state, different from compensated cirrhosis & acute decompensation (AD) @rajivjalan.bsky.social @jhepatology.bsky.social @akashroyy.bsky.social

07.03.2025 16:09 — 👍 8    🔁 3    💬 1    📌 0

Please share your views about whether the PSVD nomenclature is the way forward or an oversimplification. Personally, I think it is an advance but hugely respect the view of #Lohse, #Sarin and #Kamath

22.02.2025 14:29 — 👍 0    🔁 0    💬 0    📌 0

Fascinating discussion on PSVD, NCPF, Idiopathic portal hypertension ongoing in @jhepatology.bsky.social @valdig.bsky.social @ebtapper.bsky.social would be worth a skytutorial

22.02.2025 14:15 — 👍 5    🔁 2    💬 0    📌 1

Fascinating discussion on PSVD, NCPF, Idiopathic portal hypertension ongoing in @jhepatology.bsky.social @valdig.bsky.social @ebtapper.bsky.social would be worth a skytutorial

22.02.2025 14:15 — 👍 5    🔁 2    💬 0    📌 1

Hello!
I’m here to celebrate all you and your colleagues do for us patients!
Yay!! Welcome!!

20.02.2025 14:51 — 👍 1    🔁 1    💬 0    📌 0

Thanks for following Elliot… good to be here and getting out of X

20.02.2025 13:15 — 👍 4    🔁 0    💬 0    📌 0

#liversky

Rajiv is here

@rajivjalan.bsky.social

20.02.2025 13:13 — 👍 7    🔁 2    💬 0    📌 1

Hello, Liver People on Blue SKy… migrating from X…#liver twitter, @uclnews.bsky.social

20.02.2025 12:33 — 👍 6    🔁 0    💬 1    📌 0